Albert Bourla - Pfizer Insider

Group President - Vaccines, Oncology and Consumer Healthcare Business

Mr. Albert Bourla was appointed as Group President Vaccines, Oncology and Consumer Healthcare Business, Global Innovative Pharma Business of the Company. He was President and General Manager of Established Products Business Unit from December 2010 until December 2013. Area President Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 until November 2010. Area President Europe, Africa and Middle East of Pfizer Animal Health from 2005 until 2009.
Age: 52  President Since 2016      
212 733-2323  www.pfizer.com

Albert Bourla Latest Insider Trades

Management Efficiency

The company has Return on Asset of 0.05 % which means that on every $100 spent on asset it made $0.05 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.1 % implying that it generated $0.1 on every 100 dollars invested.
The company has 38.9 B in debt with debt to equity (D/E) ratio of 0.69 which is OK given its current industry classification. Pfizer Inc has Current Ratio of 1.09 demonstrating that it may have difficulties to pay its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Michael AbermanRegeneron Pharmaceuticals Inc
2015
Paula DowdyIllumina Inc
2016
Douglas McCorkleRegeneron Pharmaceuticals Inc
2007
Paul BianchiIllumina Inc
2012
David GryskaIncyte Corporation
2014
Barry FlannellyIncyte Corporation
2015
Steven SteinIncyte Corporation
2015
James ErlingerQuintiles Transnational Holding
2013
Sam SamadIllumina Inc
2016
Tristan OrpinIllumina Inc
2015
Daniel PlewRegeneron Pharmaceuticals Inc
2016
Richard LevyIncyte Corporation
2009
Diarmaid CunninghamICON Public Limited Company
2014
Sanjay ChikarmaneIllumina Inc
2015
Tina NovaIllumina Inc
2014
Matthew PosardIllumina Inc
2014
Jay MarkowitzRegeneron Pharmaceuticals Inc
2017
Peter PowchikRegeneron Pharmaceuticals Inc
2006
David HastingsIncyte Corporation
2003
Nicholas NaclerioIllumina Inc
2015
Mostafa RonaghiIllumina Inc
2008

Entity Summary

Pfizer Inc. discovers, develops, manufactures, and sells healthcare solutions worldwide. Pfizer Inc (PFE) is traded on New York Stock Exchange in USA. It is located in NEW YORK, U.S.A and employs 97,900 people. Pfizer is listed under Pharmaceutical Products category by Fama And French industry classification and specializes in Healthcare with concentration in Pharmaceuticals And Biosciences.
Did you try this?
Run Portfolio Backtesting Now
   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
Hide  View All  Next  Launch Portfolio Backtesting
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Pfizer Inc to your portfolio
Top Management
Pfizer Inc Leadership Team
John Young, President
Frank DAmelio, CFO
Douglas Lankler, President
George Lorch, Director
Pr MD, Executive
Helen Hobbs, Director, Ph.D
Shantanu Narayen, Director
James Smith, Director
Dennis Ausiello, Director, Ph.D
Mikael Dolsten, President, Ph.D
Frances Fergusson, Director, Ph.D
Stephen Sanger, Director
Ryan Crowe, Executive
Suzanne Johnson, Director
Geno Germano, President
Laurie Olson, President
Pr Dolsten, Executive
Sally Susman, President
Anthony Maddaluna, President
Freda LewisHall, President
Rady Johnson, President
W Cornwell, Director
Constance Horner, Director
Ian Read, Chairman
James Kilts, Director
Don Cornwell, Director
Charles Hill, President
Joseph Echevarria, Director
Albert Bourla, President
Kirsten LundJurgensen, President, Ph.D
Kathrin Jansen, President, Ph.D
Stock Performance
Pfizer Performance Indicators